Skip to main content

Table 2 Immunohistochemical staining results in the three patient groups (mTOR, PTEN, and TGF-β1 in acinus)

From: Role of the mTOR pathway in minor salivary gland changes in Sjogren’s syndrome and systemic sclerosis

  

Negative

Mild positivity

Moderate positivity

Strong positivity

mTOR

SS

3 (6)

25 (46)

20 (37)

6 (11)

Overlap syndrome

0

11 (55)

9 (45)

0

SSc

1 (9)

4 (36)

5 (46)

1 (9)

PTEN

SS

6 (13)

23 (49)

18 (38)

Overlap syndrome

8 (42)

5 (26)

6 (32)

SSc

0

7 (58)

5 (42)

TGF-β1

SS

23 (42)

20 (36)

10 (18)

2 (4)

Overlap syndrome

3 (14)

10 (48)

4 (19)

4 (19)

SSc

3 (27)

2 (18)

1 (9)

5 (46)

  1. All values are shown as n (%)
  2. mTOR mammalian target of rapamycin, PTEN phosphatase and tensin homolog, SS Sjogren’s syndrome, SSc systemic sclerosis, TGF transforming growth factor